Amber Salzman - CEO @ Epicrispr Biotechnologies

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title CEO
Primary Organization
Epicrispr Biotechnologies

Location Merion Station, Pennsylvania, United States
Regions Greater Philadelphia Area, Great Lakes, Northeastern US
Gender Female

LinkedIn View on LinkedIn

Amber Salzman is the CEO of Epic-Bio.

Jobs

Number of Current Jobs

Number of Past Jobs

Amber Salzman

has

current jobs including

CEO

Epicrispr Biotechnologies

President & CEO & Co-Founder

AAVLife

, and

President

Stop ALD Foundation

. Additionally,

Amber Salzman

has had

past jobs including

President & CEO

Ohana Biosciences

Epicrispr Biotechnologies CEOOct 2021
AAVLife President & CEO & Co-Founder
Stop ALD Foundation President

Organization Name	Title At Company	Start Date	End Date
Ohana Biosciences	President & CEO	Jul 2018	2021
Adverum Biotechnologies	President and Chief Executive Officer	Oct 2016	May 2018
Cardiokine	President and CEO	May 2009	Dec 2011
GlaxoSmithKline	Member	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Amber Salzman

holds

board and advisor roles as

Board Member

The Biotechnology Industry Organization

and

Board Member

Osler Diagnostics

The Biotechnology Industry Organization Board MemberOct 2020
Osler Diagnostics Board MemberJun 2020

Organization Name	Title At Company	Start Date	End Date
Adverum Biotechnologies	Board Member	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Health Care Early Stage Companies With Fewer Than 100 Employees	26,064
University of California, San Francisco Alumni Founded Companies	94,018
Biotechnology Early Stage Companies With More Than 10 Employees	25,751
Biotechnology Early Stage Companies With Fewer Than 50 Employees	28,485
Ally Bridge Group Portfolio Companies	78,007
United States Startups Founded in 2018	20,804
United States Biotechnology Companies with Early Stage Venture Funding	37,853
United States Health Care Companies with Early Stage Venture Funding	39,091
Biotechnology Early Stage Companies With Fewer Than 1000 Employees	23,587
Biotechnology Companies with Early Stage Venture Funding	24,560

Events

Number of Events

Amber Salzman

has participated in

event,

OrphanDrug Congress USA 2017

Apr 19, 2017

OrphanDrug Congress USA 2017 Speaker Washington, District of Columbia, United States, North AmericaApr 19, 2017